Hematopoietic Cell Transplantation (HCT) For Fanconi Anemia (FA): Comparable Outcomes Regardless Of Stem Cell Source

被引：2
|
作者：
MacMillan, Margaret L.
Defor, Todd E.
Wagner, John E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3706.3706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3706
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi Anemia.
    Fumani, Hosein Kamranzadeh
    Zokaasadi, Mohammad
    Kasaeian, Amir
    Alimoghaddam, Kamran
    Mousavi, Asadollah
    Bahar, Babak
    Vaezi, Mohammad
    Ghavamzadeh, Ardeshir
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
  • [22] Sustained Engraftment in Fanconi Anemia (FA) Mice Using in Utero Hematopoietic Cell Transplantation (IUHCT)
    Dave, Apeksha
    Liu, Suying
    Riley, John S.
    Bose, Sourav
    Menon, Pallavi
    Kurre, Peter
    Peranteau, William H.
    BLOOD, 2022, 140 : 7356 - 7357
  • [23] Fanconi anemia and haploidentical stem cell transplantation
    Medina-Valencia, Diego
    Aristizabal, Ana Maria
    Beltran, Estefania
    Franco, Alexis A.
    PEDIATRIC TRANSPLANTATION, 2022, 26 (07)
  • [24] Alternative donor hematopoietic cell transplantation for Fanconi anemia
    MacMillan, Margaret L.
    DeFor, Todd E.
    Young, Jo-Anne H.
    Dusenbery, Kathryn E.
    Blazar, Bruce R.
    Slungaard, Arne
    Zierhut, Heather
    Weisdorf, Daniel J.
    Wagner, John E.
    BLOOD, 2015, 125 (24) : 3798 - 3804
  • [25] Is hematopoietic stem cell homing deficient in Fanconi anemia?
    O'Neill, Lee
    Skinner, Amy M.
    Kurre, Peter
    BLOOD, 2009, 113 (21) : 5361 - 5361
  • [26] COMPARABLE OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION REGARDLESS OF DONOR SOURCES IN PEDIATRIC NON-MALIGNANT DISEASE
    Suh, J. K.
    Seo, J. J.
    Lee, S. W.
    Koh, K. N.
    Cho, Y. U.
    Choi, E. S.
    Jang, S.
    Im, H. J.
    Park, C. J.
    HAEMATOLOGICA, 2015, 100 : 117 - 118
  • [27] Hematopoietic stem cell transplantation (HSCT) as curative therapy for Fanconi anemia (FA) patients with acute leukemia or advanced myelodysplasia (MDS).
    Fraser, CJ
    Wagner, JE
    MacMillan, ML
    BLOOD, 2005, 106 (11) : 453B - 453B
  • [28] Late Effects Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From Alternative Donors In Patients With Fanconi Anemia (FA)
    Anur, Praveen
    Friedman, Danielle
    Sklar, Charles A.
    Oeffinger, Kevin C.
    Prockop, Susan E.
    Kernan, Nancy A.
    Scaradavou, Andromachi
    O'Reilly, Richard J.
    Boulad, Farid
    BLOOD, 2013, 122 (21)
  • [29] Hematopoietic stem cell transplantation (SCT) in fanconi anemia (FA) patients: How long is long term follow-up?
    Bonfim, C.
    Bitencourt, M.
    deMedeiros, C.
    Setubal, D.
    Ruiz, J.
    Quiroga, M.
    Beltrame, M.
    Funke, V.
    Zanis-Neto, J.
    Pasquini, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 48 - 48
  • [30] Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia
    Ebens, Christen L.
    Defor, Todd E.
    Tryon, Rebecca
    Wagner, John E.
    MacMillan, Margaret L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 765 - 771
12345